Time to castration-resistant prostate cancer (CRPC) by PSMA PET/CT bone lesion cohort at initial staging....Society of Nuclear Medicine and Molecular Imaging
Dana-Farber Research: RAS(ON) Inhibitor Doubles Median Overall Survival in Results of Phase 3 Trial for Patients with Me...Dana-Farber Cancer Institute
Workflow for prediction of 177Lu-PSMA therapy absorbed dose using pre-therapy 18F-PSMA PET/CT....Society of Nuclear Medicine and Molecular Imaging
